SEARCH

SEARCH BY CITATION

References

  • 1
    Morrison LA, Lukacher AE, Braciale VL, Fan DP, Braciale TJ. Differences in antigen presentation to MHC class I- and class II-restricted influenza virus-specific cytolytic T-lymphocyte clones. J Exp Med 1986; 186: 90321.
  • 2
    Ferrone S, Marincola FM. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 1995; 16: 48794.
  • 3
    Garrido F, Ruiz-Cabello F, Cabrera T et al . Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today 1997; 18: 8995.
  • 4
    Marincola FM, Jaffe E, Hicklin DJ, Ferrone S. Escape of human solid tumors from T cell recognition: molecular mechanisms and functional significance. Am J Pathol 1999; 154: 74554.
  • 5
    Bodmer WF, Browning MJ, Krausa P, Rowan A, Bicknell DC, Bodmer JG. Tumor escape from immune response by variation in HLA expression and other mechanisms. Ann NY Acad Sci 1993; 690: 429.
  • 6
    Vitale M, Pelusi G, Taroni B, Gobbi G, Mecheloni C. HLA class I antigen down-regulation in primary ovary carcinoma lesions: Association with disease stage. Clin Cancer Res 2005; 11: 6772.
  • 7
    Redondo M, Concha A, Ruiz-Cabello F et al . Class I major histocompatibility complex antigens and tumor ploidy in breast and bronchogenic carcinomas. Cancer Detect Prev 1997; 21: 228.
  • 8
    Redondo M, Concha A, Oldiviela R et al . Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters. Cancer Res 1991; 51: 494854.
  • 9
    Hosch SB, Meyer AJ, Schneider C et al . Expression and prognostic significance of HLA class I, ICAM-1, and tumor-infiltrating lymphocytes in esophageal cancer. J Gastrointest Surg 1997; 1: 31623.
  • 10
    Watson NF, Ramage JM, Madjd Z et al . Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis. Int J Cancer 2006; 118: 610.
  • 11
    Redondo M, Ruiz-Cabello F, Concha A et al . HLA class I expression in non-small cell lung cancer is independent of c-myc activation. Cancer Res 1991; 51: 24638.
  • 12
    Korkolopoulou P, Kaklamanis L, Pezzella F, Harris AL, Gatter KC. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. Br J Cancer 1996; 73: 14853.
  • 13
    Ramnath N, Tan D, Li Q et al . Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival? Cancer Immunol Immunother 2006; 55: 8919.
  • 14
    Torigoe T, Asanuma H, Shimozawa K et al . Immunohistochemical analysis of HLA class I expression in tumor tissues revealed unusually high frequency of down-regulation in breast cancer tissues. J Transl Med (in press).
  • 15
    Kitamura H, Torigoe T, Honma I et al . Effect of human leukocyte antigen class I expression of tumor cells on outcome of intracesical instillation of Bacillus Calmette-Guerin immunotherapy for bladder cancer. Clin Cancer Res 2006; 12: 46414.
  • 16
    Tsukahara T, Kawaguchi S, Torigoe T et al . Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5. Cancer Sci 2006; 97: 137480.
  • 17
    Kitamura H, Honma I, Torigoe T et al . Down-regulation of HLA class I antigen is an independent prognostic factor for clear cell renal cell carcinoma. J Urology 2007; 177: 126972.
  • 18
    Wakabayashi O, Yamazaki K, Oizumi S et al . CD4+T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancer. Cancer Sci 2003; 94: 10039.
  • 19
    WHO. Histological typing of lung tumours, ed 2. Am J Clin Pathol 1982; 77: 12336.
  • 20
    American Joint Committee on Cancer. Lung. In: BeahrsOH, HensonDE, HutterRVP, KennedyBJ, eds. Manual for Staging of Cancer. Philadelphia: Lippincott, 1992; 11522.
  • 21
    Naito Y, Saito K, Shiiba K et al . CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 1998; 58: 34914.
  • 22
    Ryschich E, Notzel T, Hinz U et al . Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma. Clin Cancer Res 2005; 11: 498504.
  • 23
    Garrido F, Cabrera T, Concha A, Glew S, Ruiz-Cabello F, Stern PL. Natural history of HLA expression during tumour development. Immunol Today 1993; 14: 4919.
  • 24
    Pao W, Miller V, Zakowski M et al . EGF receptor gene mutations are common in lung cancers from ‘never smokers’ and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 2004; 101: 13 30611.
  • 25
    Toyooka S, Tokumo M, Shigematsu H et al . Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers. Cancer Res 2006; 66: 13715.
  • 26
    Coca S, Perez-Piqueras J, Martinez D et al . The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 1997; 79: 23208.
  • 27
    Sandel MH, Speetjens FM, Menon AG et al . Natural killer cells infiltrating colorectal cancer and MHC class I expression. Mol Immunol 2005; 42: 5416.
  • 28
    Kooi S, Zhang HZ, Patenia R, Edwards CL, Platsoucas CD, Freedman RS. HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and t-cell expansion in vitro in low concentrations of recombinant lnterleukin-2. Cellular Immunol 1996; 174: 11628.
  • 29
    Cho Y, Miyamoto M, Kato K et al . CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma. Cancer Res 2003; 63: 15559.
  • 30
    Schmacher K, Haensch W, Roefzaad C, Schlag PM. Prognostic significance of activated CD8+ T cell infiltrations within esophageal carcinomas. Cancer Res 2001; 61: 39326.
  • 31
    Nakano O, Sato M, Naito Y et al . Proliferative activity of intratumoral CD8+ T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res 2001; 61: 51326.
  • 32
    Hiraoka K, Miyamoto M, Suzuoki M et al . Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma. Br J Cancer 2006; 94: 27580.